Trial reportEuropean journal of nutrition2026
Distinct effects of supplementation with resistant starch and polydextrose on plasma and faecal bile acid profile and associations with gut microbiota: a randomised, controlled intervention in healthy participants.
Trial report in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01214681 (Chemoprevention of Colorectal Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
purposeDietary fibre may influence bile acid (BA) metabolism via interactions with gut microbiota. We hypothesised that dietary fibres with distinct fermentative properties, resistant starch (RS) and polydextrose (PD), would differentially alter BA profiles in plasma and faeces through gut microbiota-mediated mechanisms.
methodsBA profiles were analysed by ultra-performance liquid chromatography mass spectrometry in plasma (n = 74) and faeces (n = 50) from a double-blind, randomised, placebo-controlled 2 × 2 factorial trial. Healthy participants consumed 23 g/day Hi-maize
resultsSupplementation with RS, but not PD, increased a range of conjugated BAs and deoxycholic acid (FDR < 0.05). Concentrations of taurochenodeoxycholic acid (FDR = 0.027) and taurine conjugated BAs (FDR = 0.049) in plasma correlated positively with Akkermansia abundance in response to RS. Although neither RS nor PD altered BA concentrations in faeces, RS decreased (p = 0.032) and PD increased (p = 0.012) faecal proportions of primary BAs. PD reduced secondary BA transformation ratios (p < 0.05), along with shifts in related microbial associations. There were negative correlations between plasma primary conjugated BAs and faecal secondary BAs in response to RS specifically (p < 0.05).
conclusionRS increased plasma BAs, particularly conjugated BAs, whereas PD reduced faecal secondary BA transformation. The distinct impacts of RS and PD on BA profiles and fibre-specific microbial associations may underlie their differential metabolic effects. Trail registration The DISC Study was registered with https://clinicaltrials.gov/ (Identifier NCT01214681) in 2010.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.